Supplementary Figure S5 from Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S5 Mean tumor volume and corresponding mouse weights for cohorts of mice bearing the Ewing sarcoma xenografts TC32 or TC71 as a function of days of treatment with vehicle control (black), lurbinectedin (red), irinotecan (blue) or the combination of lurbinectedin and irinotecan (green).
Authors: Matt L. Harlow, Nichole Maloney, Joseph Roland, Maria Jose Guillen Navarro, Matthew K. Easton, Susan M. Kitchen-Goosen, Elissa A. Boguslawski, Zachary B. Madaj, Ben K. Johnson, Megan J. Bowman, Maurizio D'Incalci, Mary E. Winn, Lisa Turner, Galen Hostetter, Carlos María Galmarini, Pablo M. Aviles, Patrick J. Grohar
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361972101
